RxDoctor Payments Data

Penny Bruso

Family · Shaftsbury, VTNPI 1518376607

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.6% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 25.1% of the total. Reporting peaked in 2022 at $872 and has fallen 94.3% since, to $50 in 2025. Among family clinicians in VT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,964in general payments, 2019–2025

Across 108 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$492
  • Biogen$205
  • Sanofi$187
  • Bristol Myers Squibb$153
  • AstraZeneca$131
  • Johnson & Johnson$103
  • plus $691 from 16 others

What the payments were for

  • Food & beverage$1,80092%
  • Education$1648%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,964 in reported general payments places this provider in the 90th percentile of 75 family providers in Vermont.

See all family providers in Vermont

Most prescribed under Part D

DrugClaimsCost to plans & patients
OctagamImmun Globg(Igg)/Malt/Iga Ov5012$181,343
Kesimpta PenOfatumumab12$103,138
Nurtec OdtRimegepant Sulfate30$48,943
Dalfampridine ErDalfampridine42$22,149
BotoxOnabotulinumtoxina12$14,839
Pyridostigmine Bromide22$3,190
Modafinil25$2,393
Sumatriptan Succinate36$1,864
Baclofen102$1,749
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine13$1,240
Gabapentin75$1,110
Azathioprine12$744
Lamotrigine40$625
Duloxetine Hcl28$531
Tizanidine Hcl30$337

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerOctagam, Nurtec Odt$96$230,28642 claims
AbbVieBotox$492$14,83912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 75 family providers in Vermont.

Other family in Shaftsbury

See the full list for Vermont

Where these figures come from

Is this you, or does something look wrong? →